Does Insurance Cover Ozempic, Wegovy, or Mounjaro? (2026 Guide)

Q: Does Medicaid cover Wegovy or Ozempic?

Medicaid coverage for GLP-1 weight loss medications varies by state. Some state Medicaid programs cover Wegovy for obesity treatment; others do not. Ozempic for type 2 diabetes is more broadly covered. Check with your state Medicaid plan or a clinic that accepts Medicaid.

GLP-1 medications are transformative — and expensive. Brand-name Wegovy costs over $1,100/month without coverage. Mounjaro runs $1,000+. For most people, whether insurance covers their GLP-1 drug isn't a minor question. It determines whether treatment is financially possible at all.

Here's the honest breakdown of how coverage works in 2026 — across commercial insurance, Medicare, and Medicaid — and what you can actually do if your plan says no.

Commercial Insurance (Employer-Sponsored Plans)

This is where you're most likely to get coverage, but it's not guaranteed.

Many large employers now include Wegovy (semaglutide) and Zepbound (tirzepatide) on their drug formularies for obesity treatment. Requirements typically include:

BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (hypertension, sleep apnea, type 2 diabetes, high cholesterol)
Prior authorization from your physician documenting medical necessity
Documentation that lifestyle modifications (diet, exercise) have been attempted

Ozempic and Mounjaro — the diabetes-labeled versions of the same drugs — have broader commercial formulary coverage but are officially approved for type 2 diabetes, not obesity. Some plans cover them off-label for weight loss; most don't, and off-label coverage is increasingly scrutinized.

Medicare

This is the current gap that affects millions of older Americans. Medicare Part D covers Ozempic for type 2 diabetes but does not yet cover anti-obesity medications like Wegovy for weight loss alone. The Treat and Reduce Obesity Act has been introduced in Congress repeatedly — if it passes, it would require Medicare to cover GLP-1 drugs for obesity. As of 2026, it has not passed.

If you're on Medicare and want GLP-1 treatment for weight loss, your options are compounded semaglutide (cash-pay), patient assistance programs from Novo Nordisk or Eli Lilly, or a manufacturer coupon if you have any supplemental coverage.

Medicaid

Coverage varies dramatically by state. Some state Medicaid programs — including California Medi-Cal, Illinois Medicaid, and several others — now cover Wegovy for obesity treatment. Many do not. Ozempic for type 2 diabetes is more broadly covered across state Medicaid plans.

Your best path: call your state Medicaid plan's pharmacy benefits line and ask specifically about "semaglutide for obesity" or "tirzepatide for obesity." Have your BMI and diagnosis code handy.

How to Get Prior Authorization Approved

Most commercial plans require prior authorization (PA) for GLP-1 weight loss drugs. The clinic you work with typically handles this process, but you should know what it involves:

Step 1: Your physician documents your BMI, diagnosis (obesity, E66.01), and any comorbidities
Step 2: PA submitted to your insurer with a letter of medical necessity
Step 3: Insurer may require "step therapy" — proving you've tried a cheaper weight loss drug first (usually phentermine or orlistat)
Step 4: Approval or denial. Denials can be appealed — approximately 40-60% of denied GLP-1 PAs are approved on appeal

When choosing a clinic, ask specifically: "Do you handle prior authorizations in-house, and do you have experience getting GLP-1 PAs approved with [your insurer]?" This is one of the most valuable things a physician-supervised program offers that telehealth-only services often can't.

What If Your Insurance Won't Cover It?

You have real options beyond just paying full price:

Manufacturer savings programs: Novo Nordisk's Wegovy WeightLoss.com savings card and Eli Lilly's savings card can bring monthly cost to $25–$0 for commercially insured patients who qualify
Compounded semaglutide: $150–$350/month through licensed 503B compounding pharmacies — the same active ingredient, significantly lower cost. Availability depends on FDA shortage status
Patient assistance programs: Both Novo Nordisk and Eli Lilly have programs for uninsured or underinsured patients who meet income requirements
Appeal your denial: Ask your physician to write a strong letter of medical necessity citing relevant comorbidities. First-level appeals succeed more often than people expect

Frequently Asked Questions

Does Medicare cover Ozempic for weight loss?

Medicare Part D covers Ozempic only when prescribed for type 2 diabetes. The Inflation Reduction Act does not yet require Medicare to cover anti-obesity medications for weight loss alone, though legislation has been introduced to change this.

Does Medicaid cover Wegovy or Ozempic?

Medicaid coverage varies by state. Some state Medicaid programs cover Wegovy for obesity treatment; others do not. Ozempic for type 2 diabetes is more broadly covered. Check with your state Medicaid plan or a clinic that accepts Medicaid.

How do I get my insurance to cover Wegovy?

Most commercial insurers require a prior authorization for Wegovy. Your physician will need to document your BMI (≥30, or ≥27 with a comorbidity), failed attempts at lifestyle modification, and the medical necessity of pharmacotherapy. Work with a clinic that handles prior authorizations — some will do this on your behalf.